Rita Dobmeyer
Direktor/Vorstandsmitglied bei Blueberry Therapeutics Ltd.
Ursprung des Netzwerks ersten Grades von Rita Dobmeyer
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rita Dobmeyer
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Close Asset Management (UK) Ltd.
Close Asset Management (UK) Ltd. Investment ManagersFinance Close Asset Management (UK) Ltd., doing business as Close Brothers Asset Management (CBAM), is an investment management firm headquartered in London, UK. The firm is a subsidiary of Close Asset Management Holdings Ltd., itself a subsidiary of Close Brothers Group Plc (LON: CBG). The firm was formerly known as Close Investments Ltd. in 1994 and changed into their current name when Close Brothers Investment, Close Investment, Close Finsbury Asset Management, and Reabourne Technology Investment Management were reorganized into a single legal entity in 2009. CBAM provides a wide variety of financial advisory and investment management services to UK and international intermediaries, private individuals, and institutions such as pension funds. They also manage discretionary portfolios as well as a diverse range of investment products. | Investment Managers | Portfolio Manager-Equities | |
China Medical Venture Investment Hk Ltd. | Director/Board Member | ||
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | Medical/Nursing Services | Director/Board Member | |
University of London | College/University | Doctorate Degree | |
EVOTEC SE | Pharmaceuticals: Major | Corporate Officer/Principal | |
MALIN CORPORATION PLC | Biotechnology | Chief Executive Officer | |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Joh. Berenberg, Gossler & Co. KG (United Kingdom) (Berenberg-UK) is the Great Britain-based broker/dealer division of Joh. Berenberg, Gossler & Co. KG, a multinational full-service investment bank in Germany. Headquartered in London, Berenberg-UK was founded in 2003 and provides trading and brokerage services to institutional and corporate clients. | Investment Banks/Brokers | Analyst-Equity | |
ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
Cambridge United China Collaborations Ltd. | Director/Board Member | ||
China Medstar Ltd.
China Medstar Ltd. Medical DistributorsDistribution Services China Medstar Ltd. supplies and leases radiotherapy equipment for cancer treatment. The company have sixteen operational centers, ten radiotherapy, two nuclear medicine examine (including ECT and PET-CT) and MR, and one HIFU and ophthalmic center. The company was established in 2003 and is headquartered in Beijing, China. | Medical Distributors | Director/Board Member | |
A&B (HK) Co. Ltd.
A&B (HK) Co. Ltd. Electronic Equipment/InstrumentsElectronic Technology A & B (HK) Co. Ltd. is a Chinese company that manufactures and distributes portable neuro-modulation stimulator devices. The private company is based in Hong Kong, Hong Kong. The CEO of the company is Huai Zheng Peng. | Electronic Equipment/Instruments | Chief Executive Officer | |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
DESTINY PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
Hunan University of Chinese Medicine | College/University | Graduate Degree | |
UCL Medical School | College/University | Doctorate Degree | |
NAVAMEDIC ASA | Medical Distributors | Director/Board Member | |
HELIUS MEDICAL TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Director/Board Member | |
CHINA MEDICAL SYSTEM HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
BIVICTRIX THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO |
Statistik
International
Vereinigtes Königreich | 15 |
Vereinigte Staaten | 6 |
China | 5 |
Irland | 3 |
Deutschland | 2 |
Sektoral
Health Technology | 17 |
Finance | 6 |
Consumer Services | 4 |
Distribution Services | 3 |
Health Services | 2 |
Operativ
Director/Board Member | 22 |
Corporate Officer/Principal | 6 |
Chief Executive Officer | 3 |
Independent Dir/Board Member | 3 |
Doctorate Degree | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Huai Zheng Peng | 19 |
Adrian Howd | 14 |
John Ridden | 1 |
- Börse
- Insiders
- Rita Dobmeyer
- Unternehmensverbindungen